Zacks Small Cap Research – LNTH: Sale of SPECT Tilts Growth to Novel Radiopharmaceuticals – Go Health Pro
By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) reported first quarter 2025 financial and operational results on May 7th, producing sales of $373 million, a 1% increase over 1Q:24 levels. Pylarify, TechneLite, and Other Precision Diagnostics saw a year over year decline which was more than offset by … Read more